Type 2M von Willebrand disease: F606I and I662F mutations in the GPIb binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets - Hillery,C.A.; Mabcusco,D.J.; Sadler,J.E. (Blood, 1998)